People with type 2 diabetes (T2D) develop Alzheimer’s disease (AD) at a rate of about 4.71 cases per 1,000 person-years, and face a 53% higher AD risk than those without T2D. These findings come from a systematic review and meta-analysis of 40 studies covering more than 27 million data points. The analysis found that incidence was 4.00 per 1,000 person-years in studies using administrative ascertainment, versus 10.24 per 1,000 person-years in those using non-administrative ascertainment. Women had a numerically higher incidence than men (3.62 vs. 2.76 per 1,000 person-years), although adjusted relative risks were similar (1.73 vs. 1.76). Findings were generally consistent across subgroups and robust in sensitivity analyses. Integrating incidence and relative risk estimates clarifies both the absolute and relative burden of AD in T2D, and supports integrating cognitive risk prevention into T2D care. Source: https://link.springer.com/
In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…
A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…
This website uses cookies.